BIXAMPLY
Live / Allowed — First extension granted (statement of use) (as of 15 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99170293
- Mark type
- Word mark
- Filed
- 05 May 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity
Owner
- Disc Medicine, Inc., Watertown, MA, US
- Disc Medicine, Inc., Watertown, MA, US
Prosecution history
- 16 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jun 2026 — SOU EXTENSION 1 GRANTED
- 15 Jun 2026 — SOU EXTENSION 1 FILED
- 15 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Sept 2025 — ASSIGNED TO EXAMINER
- 05 May 2025 — APPLICATION FILING RECEIPT MAILED
- 05 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 May 2025 — NEW APPLICATION ENTERED